Semin Liver Dis 2012; 32(01): 092-098
DOI: 10.1055/s-0032-1306429
Diagnostic Problems in Hepatology
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Late Nonalcoholic Fatty Liver Disease with Cirrhosis: A Pathologic Case of Lost or Mistaken Identity

Jay H. Lefkowitch
1   Department of Pathology and Cell Biology, Columbia University College of Physicians and Surgeons, New York, New York
,
John L. Morawski
2   Pathology, Columbia Memorial Hospital, Hudson, New York.
› Author Affiliations
Further Information

Publication History

Publication Date:
13 March 2012 (online)

Abstract

Late-stage nonalcoholic fatty liver disease (NAFLD) may present clinically and/or pathologically as cryptogenic cirrhosis. The subject of this report, a middle-aged obese man with diabetes, underwent liver biopsy at the time of laparoscopic cholecystectomy because the liver surface appeared nodular and thickened. The biopsy showed relatively nondescript cirrhosis at initial low-power microscopic inspection, but glycogenated hepatocyte nuclei (consistent with diabetes), sparse macrovesicular fat, and very rare foci of residual mild steatohepatitis were later found. Slender fibrous septa (without significant inflammation and often enclosing microvessels) were present and interconnected to portal tracts. Immunostains for cytokeratin 7, ubiquitin, and glutamine synthetase provided additional histologic data supporting NAFLD as the cause of the cirrhosis in this case. A strategic pathologic approach is discussed, which can be utilized for the pathologic assessment of cirrhosis of unknown cause, particularly when late NAFLD is suspected.

 
  • References

  • 1 Yeh MM, Brunt EM. Pathology of nonalcoholic fatty liver disease. Am J Clin Pathol 2007; 128 (5) 837-847
  • 2 Hübscher SG. Histological assessment of non-alcoholic fatty liver disease. Histopathology 2006; 49 (5) 450-465
  • 3 Tannapfel A, Denk H, Dienes H-P , et al. Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Virchows Arch 2011; 458 (5) 511-523
  • 4 Brunt EM. Non-alcoholic fatty liver disease: what's new under the microscope?. Gut 2011; 60 (8) 1152-1158
  • 5 Christoffersen P, Poulsen H, Alcoholic liver disease. In: MacSween RNM, Anthony PP, Scheuer PJ. , eds. Pathology of the Liver. Edinburgh: Churchill Livingstone; 1979: 232-247
  • 6 Porta EA, Hartroft WS, de la Iglesia FA, Structural and ultrastructural hepatic lesions associated with acute and chronic alcoholism in man and experimental animals. In: Maickel RP. , ed. Biochemical Factors in Alcoholism. Oxford: Pergamon; 1967: 201-238
  • 7 Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999; 29 (3) 664-669
  • 8 Gerber MA, Popper H. Relation between central canals and portal tracts in alcoholic hepatitis. A contribution to the pathogenesis of cirrhosis in alcoholics. Hum Pathol 1972; 3 (2) 199-207
  • 9 Gill RM, Belt P, Wilson L, Bass NM, Ferrell LD. Centrizonal arteries and microvessels in nonalcoholic steatohepatitis. Am J Surg Pathol 2011; 35 (9) 1400-1404
  • 10 Burke ZD, Reed KR, Phesse TJ, Sansom OJ, Clarke AR, Tosh D. Liver zonation occurs through a β-catenin-dependent, c-Myc-independent mechanism. Gastroenterology 2009; 136 (7) 2316-2324 , e1–e3
  • 11 Gebhardt R, Reichen J. Changes in distribution and activity of glutamine synthetase in carbon tetrachloride-induced cirrhosis in the rat: potential role in hyperammonemia. Hepatology 1994; 20 (3) 684-691
  • 12 Richardson MM, Jonsson JR, Powell EE , et al. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology 2007; 133 (1) 80-90
  • 13 Chiba M, Sasaki M, Kitamura S, Ikeda H, Sato Y, Nakanuma Y. Participation of bile ductular cells in the pathological progression of non-alcoholic fatty liver disease. J Clin Pathol 2011; 64 (7) 564-570
  • 14 Gouw ASH, Clouston AD, Theise ND. Ductular reactions in human liver: diversity at the interface. Hepatology 2011; 54 (5) 1853-1863